Theratechnologies Inc
TSX:TH
Theratechnologies Inc
TSX:TH
Price:
1.8 CAD
Market Closed
Updated:
Apr 29, 2024
Theratechnologies Inc
Cash from Investing Activities
|
Theratechnologies Inc
Cash from Investing Activities Peer Comparison
Comparables:
ZYME
RPTX
FUSN
AUPH
EDT
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Theratechnologies Inc
TSX:TH
|
Cash from Investing Activities
$1.6m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-14%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Cash from Investing Activities
-$207.3m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Cash from Investing Activities
$78m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Cash from Investing Activities
-$42.8m
|
CAGR 3-Years
41%
|
CAGR 5-Years
-107%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Cash from Investing Activities
-$6.7m
|
CAGR 3-Years
65%
|
CAGR 5-Years
-149%
|
CAGR 10-Years
-67%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Cash from Investing Activities
-CA$185k
|
CAGR 3-Years
15%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
See Also
What is Theratechnologies Inc's Cash from Investing Activities?
Cash from Investing Activities
1.6m
USD
1.6m
USD
Based on the financial report for Feb 29, 2024, Theratechnologies Inc's Cash from Investing Activities amounts to 1.6m USD.
What is Theratechnologies Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-14%
-14%
Over the last year, the Cash from Investing Activities growth was -81%. The average annual Cash from Investing Activities growth rates for Theratechnologies Inc have been -25% over the past three years , and -14% over the past ten years .
You don't have any saved screeners yet
